# Takeda Pharmaceutical Company

Type: Company (TAK)

Source: GetYourBrief — https://getyourbrief.com/entity/takeda-pharmaceutical-company
Canonical HTML page: https://getyourbrief.com/entity/takeda-pharmaceutical-company

## Recent coverage (1 stories, network-wide)

### Takeda Secures First ASEAN Plasma Fractionation License in $30M Indonesia Deal
2026-07-13 00:19:20 · Sector: bio · Sentiment: Positive · Impact: 7/10 · Sources: 2

Takeda receives Indonesia’s first plasma fractionation license, part of a $30 million collaboration to build a domestic plasma ecosystem. The initiative aims to scale manufacturing of plasma-derived medicinal products, positioning Indonesia as a regional biopharma hub.
Full story: https://getbiobrief.com/story/takeda-indonesia-30m-plasma-fractionation-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.